Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $2,500 | 1 | 80.6% |
| Food and Beverage | $601.14 | 20 | 19.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Arthrex, Inc. | $2,500 | 1 | $0 (2018) |
| Flexion Therapeutics, Inc. | $188.03 | 4 | $0 (2019) |
| Treace Medical Concepts, Inc. | $123.33 | 1 | $0 (2021) |
| Abbott Laboratories | $96.72 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $60.71 | 4 | $0 (2018) |
| Electronic Waveform Lab, Inc. | $43.49 | 2 | $0 (2020) |
| Heron Therapeutics, Inc. | $31.44 | 1 | $0 (2023) |
| Amgen Inc. | $23.64 | 1 | $0 (2023) |
| Bioventus LLC | $21.67 | 1 | $0 (2019) |
| Mid-Atlantic Surgical Systems, LLC | $12.11 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $90.97 | 4 | Abbott Laboratories ($35.89) |
| 2022 | $60.83 | 3 | Abbott Laboratories ($60.83) |
| 2021 | $123.33 | 1 | Treace Medical Concepts, Inc. ($123.33) |
| 2020 | $24.74 | 1 | Electronic Waveform Lab, Inc. ($24.74) |
| 2019 | $90.34 | 3 | Flexion Therapeutics, Inc. ($49.92) |
| 2018 | $2,680 | 7 | Arthrex, Inc. ($2,500) |
| 2017 | $30.76 | 2 | E.R. Squibb & Sons, L.L.C. ($30.76) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Neuromodulation | ||||||
| 04/28/2023 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | Cash or cash equivalent | $31.44 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 04/20/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Neuromodulation | ||||||
| 02/24/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Bone Health | ||||||
| 07/20/2022 | Abbott Laboratories | AXIUM (Device) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Neuromodulation | ||||||
| 05/26/2022 | Abbott Laboratories | AXIUM (Device) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Neuromodulation | ||||||
| 03/02/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Neuromodulation | ||||||
| 04/16/2021 | Treace Medical Concepts, Inc. | Lapiplasty System (Device) | Food and Beverage | Cash or cash equivalent | $123.33 | General |
| Category: Y | ||||||
| 11/20/2020 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.74 | General |
| 12/17/2019 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| 04/06/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $49.92 | General |
| Category: Musculoskeletal | ||||||
| 01/03/2019 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 10/05/2018 | Mid-Atlantic Surgical Systems, LLC | — | Food and Beverage | In-kind items and services | $12.11 | General |
| 09/17/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: Musculoskeletal | ||||||
| 09/17/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $1.29 | General |
| Category: Musculoskeletal | ||||||
| 09/11/2018 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $115.45 | General |
| Category: Musculoskeletal | ||||||
| 07/18/2018 | Arthrex, Inc. | — | Grant | Cash or cash equivalent | $2,500.00 | General |
| 05/10/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Cardiovascular | ||||||
| 04/03/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Cardiovascular | ||||||
| 07/21/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Cardiovascular | ||||||
| 01/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 631 | 2,268 | $299,432 | $70,580 |
| 2022 | 15 | 554 | 1,936 | $253,998 | $62,300 |
| 2021 | 12 | 288 | 877 | $111,596 | $27,970 |
| 2020 | 8 | 135 | 344 | $40,835 | $10,356 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2023 | 39 | 206 | $81,069 | $19,657 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 155 | $58,030 | $14,304 | 24.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 58 | 225 | $56,870 | $12,805 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 112 | $29,442 | $6,664 | 22.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 57 | 82 | $26,526 | $6,116 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $13,186 | $3,015 | 22.9% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 23 | 31 | $4,246 | $1,013 | 23.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 71 | 1,104 | $3,550 | $898.10 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,632 | $820.59 | 17.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 17 | 19 | $3,251 | $797.43 | 24.5% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 13 | 17 | $3,080 | $739.19 | 24.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 44 | 109 | $2,490 | $659.41 | 26.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 18 | 19 | $2,636 | $646.78 | 24.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 15 | 17 | $2,684 | $622.59 | 23.2% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 15 | 15 | $2,267 | $541.36 | 23.9% |
| 73610 | X-ray of ankle, minimum of 3 views | Office | 2023 | 14 | 18 | $1,960 | $461.09 | 23.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 16 | 18 | $1,839 | $426.88 | 23.2% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 17 | 80 | $1,674 | $394.52 | 23.6% |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | Office | 2022 | 27 | 140 | $56,810 | $14,281 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 126 | $46,184 | $11,826 | 25.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 52 | 173 | $44,352 | $9,952 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 133 | $34,499 | $8,455 | 24.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 38 | 61 | $20,235 | $4,616 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $18,202 | $4,364 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 33 | 33 | $10,878 | $2,667 | 24.5% |
About Dr. Matthew Flanagan, D.O
Dr. Matthew Flanagan, D.O is a Sports Medicine healthcare provider based in Canonsburg, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811186133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Flanagan, D.O has received a total of $3,101 in payments from pharmaceutical and medical device companies, with $90.97 received in 2023. These payments were reported across 21 transactions from 10 companies. The most common payment nature is "Grant" ($2,500).
As a Medicare-enrolled provider, Flanagan has provided services to 1,608 Medicare beneficiaries, totaling 5,425 services with total Medicare billing of $171,206. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Sports Medicine
- Location Canonsburg, PA
- Active Since 10/23/2007
- Last Updated 10/13/2020
- Taxonomy Code 207RS0010X
- Entity Type Individual
- NPI Number 1811186133
Products in Payments
- Zilretta (Drug) $188.03
- Lapiplasty System (Device) $123.33
- ELIQUIS (Drug) $60.71
- PROCLAIM (Device) $60.47
- AXIUM (Device) $36.25
- ZYNRELEF (Drug) $31.44
- EVENITY (Biological) $23.64
- Durolane (Device) $21.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.